Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)
DOI: 10.1128/aac.01805-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Lucía González-Pinto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología Clínica & Grupo de Investigación en Microbiología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hosp…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, beta-Lactamases, Carbapenems, Anti-Bacterial Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Axencia Galega de Innovación, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III.
Abstract (Originalsprache)
We aimed to characterize OXA-1054, a novel carbapenem-hydrolyzing class D β-lactamase (CHDL) detected in a multidrug-resistant Pseudomonas aeruginosa clinical isolate. Antimicrobial susceptibility was determined by broth microdilution, and carbapenemase activity was confirmed by hydrolysis assays. Whole-genome sequencing via Illumina and PacBio platforms enabled comprehensive analysis of the resistome and plasmid architecture. The bla OXA-1054 gene was cloned in parallel with bla OXA-48 and bla OXA-198 into the pUCP24 plasmid. β-Lactamases were produced in P. aeruginosa PAO1 for comparative evaluation of the phenotypic impact of each. OXA-48, OXA-198, and OXA-1054 β-lactamases were purified and further subjected to steady-state kinetic analysis, and 50% inhibitory activity of β-lactamase inhibitors was determined. The clinical P. aeruginosa isolate ARGA00461 showed resistance to carbapenems and most β-lactam/β-lactamase inhibitor combinations and tested positive in carbapenem hydrolysis assays. Genomic analysis revealed that the P. aeruginosa isolate ARGA00461 carried a gene coding for a previously uncharacterized CHDL, designated OXA-1054, which is closely related to the OXA-372 enzyme of environmental origin. The bla OXA-1054 gene was located in a small (≈5 kbp) non-conjugative plasmid coexisting with a conjugative IncP plasmid, which likely facilitated its mobilization. Production of OXA-1054 in P. aeruginosa PAO1 conferred a broader spectrum of β-lactam resistance than other CHDLs. Enzyme kinetics confirmed carbapenem hydrolysis with catalytic efficiency comparable to OXA-48 and revealed higher affinity for cefepime compared to OXA-48 and OXA-198. Among the inhibitors tested, only avibactam demonstrated relevant inhibitory activity. OXA-1054 mediates broad-spectrum β-lactam resistance in P. aeruginosa , including carbapenems and β-lactam/β-lactamase inhibitor combinations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Microbiología Clínica & Grupo de Investigación en Microbiología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), SERGAS, Universidade da Co…
- CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, España.
- Instituto de Biomedicina de Sevilla IBIS, Hospital Universitario Virgen Macarena/CSIC/Universidad de Sevilla, Seville, Spain.
- Departamento de Microbiología, Facultad de Medicina, Universidad de Sevilla, Seville, Spain.
- Servicio de Microbiología, Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma de Mallorca, Spain.
- Unidad de Enfermedades Infecciosas y Microbiología Clínica, Hospital Universitario Virgen Macarena, Seville, Spain.
ORCID-Profile: Lucía González-Pinto, Laura Monge-Olivares, Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía Sánchez-Peña, María Antonia Gomis-Font, Salud Rodríguez-Pallares, Tania Blanco-Martín, Lorena López-Cerero, Alejandro Beceiro, Antonio Oliver, Germán Bou, Jorge Arca-Suárez
Förderung
- Axencia Galega de Innovación
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC)
- Instituto de Salud Carlos III
Zitieren
APA
González-Pinto, L., Monge-Olivares, L., Pérez-Rodríguez, G., Aja-Macaya, P., Sánchez-Peña, L., Gomis-Font, M. A., Rodríguez-Pallares, S., Blanco-Martín, T., López-Cerero, L., Beceiro, A., Bogaerts, P., Oliver, A., Bou, G., & Arca-Suárez, J. (2026). Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.01805-25
Vancouver
González-Pinto L, Monge-Olivares L, Pérez-Rodríguez G, Aja-Macaya P, Sánchez-Peña L, Gomis-Font MA, et al. Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.01805-25
BibTeX
@article{GonzlezPinto2026,
author = {González-Pinto, Lucía and Monge-Olivares, Laura and Pérez-Rodríguez, Gloria and Aja-Macaya, Pablo and Sánchez-Peña, Lucía and Gomis-Font, María Antonia and Rodríguez-Pallares, Salud and Blanco-Martín, Tania and López-Cerero, Lorena and Beceiro, Alejandro and Bogaerts, Pierre and Oliver, Antonio and Bou, Germán and Arca-Suárez, Jorge},
title = {Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {7},
doi = {10.1128/aac.01805-25}
}
EUVIMED